Arctic Bioscience - Presentation for today's webcast

16 Oct 2024 08:00 CEST

With reference to yesterday's stock exchange release regarding webcast to be
hosted today at 12:00 CET to present the results from the HeROPA read-out.

Attached is the presentation material which will be presented at this webcast.

The webcast will be hosted by CEO Christer L. Valderhaug and Medical Director
Runhild Gammelsæter.

Webcast details:

Date: Wednesday 16[th] of October 2024

Time: 12:00 CET

Format: Webcast

Language: English

The presentation can be accessed through the link below:

Link: https://channel.royalcast.com/landingpage/hegnarmedia/20241016_1/

This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.

For more information, please contact:

Christer L. Valderhaug

CEO

Mobile: +47 920 84 601

E-mail: christer@arctic-bioscience.com

About Arctic Bioscience

Arctic Bioscience is a biotech company developing and commercializing
pharmaceutical and nutraceutical products based on unique bioactive marine
compounds.

The company is developing HRO350 - a novel oral drug candidate. HRO350 is being
developed for treatment of patients with mild-to-moderate psoriasis. This is a
large patient group in need of new effective medicines with beneficial safety
profile.

Nutraceuticals from Arctic Bioscience are sold globally as bulk ingredients as
well as finished goods under the ROMEGA® brand.

Arctic Bioscience is led by a highly skilled team of talents with diverse and
highly relevant background.

More information:
Access the news on Oslo Bors NewsWeb site

629694_20241016_Presentation_HeROPA_read_out.pdf